| Stage | STE | % of rev | APT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.6B | 100.00% | $19M | 100.00% | STE ×85.07 |
| Gross profit | $711M | 44.74% | $7M | 37.37% | STE +7.4pp |
| Operating income | $294M | 18.53% | $2M | 10.77% | STE +7.8pp |
| Pre-tax income | $288M | 18.13% | $2M | 12.77% | STE +5.4pp |
| Net income | $214M | 13.48% | $2M | 9.78% | STE +3.7pp |
| Stage | STE | APT | Gap · A − B |
|---|---|---|---|
| Revenue | $1.6B100.00% | $19M100.00% | STE ×85.07 |
| Gross profit | 44.74%$711M | 37.37%$7M | STE +7.4pp |
| Operating income | 18.53%$294M | 10.77%$2M | STE +7.8pp |
| Pre-tax income | 18.13%$288M | 12.77%$2M | STE +5.4pp |
| Net income |
| 13.48%$214M |
| 9.78%$2M |
| STE +3.7pp |
None
No disclosed counterparties: STE.